Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group.
about
Epidemiology and etiology of childhood pneumoniaAntibiotics for community-acquired pneumonia in childrenAntibiotics for community-acquired pneumonia in childrenDoes 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.The effect of case management on childhood pneumonia mortality in developing countries.Why has so little changed in maternal and child health in south Asia?Novel expansions of the gene encoding dihydropteroate synthase in trimethoprim-sulfamethoxazole-resistant Streptococcus pneumoniae.Experience developing national evidence-based clinical guidelines for childhood pneumonia in a low-income setting--making the GRADE?Childhood cause-specific mortality in rural Western Kenya: application of the InterVA-4 model.Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model.Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G.Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia.Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation.A reversal in reductions of child mortality in western Kenya, 2003-2009.Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in PakistanImpact of antibiotic resistance on the treatment of sepsis.Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey.Frequency and trajectory of abnormalities in respiratory rate, temperature and oxygen saturation in severe pneumonia in children.Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trialChloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).Pneumonia research to reduce childhood mortality in the developing world.Does antibiotic selection impact patient outcome?Severe community-acquired pneumonia: approach to therapy.Dealing with childhood pneumonia in developing countries: how can we make a difference?Treatment failure among Kenyan children with severe pneumonia--a cohort study.Credit where credit is due: Pakistan's role in reducing the global burden of reproductive, maternal, newborn, and child health (RMNCH)Case management of childhood pneumonia in developing countries.Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trialClinical Effectiveness of Co-trimoxazole vs. Amoxicillin in the Treatment of Non-Severe Pneumonia in Children in India: A Randomized Controlled TrialCost-effectiveness analysis of revised WHO guidelines for management of childhood pneumonia in 74 Countdown countries.Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence.Evaluating the impact of pulse oximetry on childhood pneumonia mortality in resource-poor settings.Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children.Clinical failure among children with nonsevere community-acquired pneumonia treated with amoxicillin.Childhood pneumonia--preventing the worlds biggest killer of children.Editorial commentary: ambulatory management of chest-indrawing pneumonia.Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis.Quinolone resistance among pneumococci: therapeutic and diagnostic implications.
P2860
Q22241278-ED04940D-4ADC-4542-B150-89353982FA89Q24202296-AF7D48FB-1B75-4FEB-B4FC-B50032E175E3Q24236788-0ACA5875-7C2E-495A-9558-7B3E46EF95AFQ33330280-7DFFC911-A2C6-498A-BD65-5BD13B7B4E62Q33754512-1B8371BC-7220-4CD0-B62D-8E10B60B963CQ33802093-4E999464-8147-4ECC-A100-87B04A7E8069Q33977648-6AB9E25F-A3B5-4545-A495-2FBBEC4A439EQ34114429-0F35919D-18D6-4519-A105-74A967D4247CQ34458816-0F9ECB6F-8F34-45D7-BCAA-380721B7A736Q34471089-6EC6E2A1-0785-4408-B384-F2F5D57004F4Q34603888-F2A4D35B-6661-43FE-A67D-A563EB16EE7EQ34734294-206C6B21-6A25-4CED-9B54-1BE870BB2839Q34951125-90BE3B52-AFD7-4005-98FB-F4593B66FF94Q35245932-D1555B84-F5CA-402E-8153-514FD1561A1EQ35567226-D4F671EB-0250-4BB3-A2A7-841FFC7900DBQ35585103-5398FCDE-2B80-41D5-A153-B3FE2AE19507Q35626690-1578DD21-BB1F-4993-A032-C6EC2A870423Q36103403-B736EE94-816E-4A07-A0FD-1F3546D47112Q36155303-0C79A947-2FDD-4A8F-8AC3-38A88AE5A097Q36169115-4B05DFA6-0011-464C-BD5C-662D65957C5FQ36359495-7DE0C770-FF1C-4A29-AB93-E837851D3D87Q36513346-4262851B-2947-4CCC-B404-21BEA4EB62B7Q36672883-A809BC0E-3A5C-4A15-BFFA-479E4E9A22D7Q36765778-F81E83AB-72CC-49C5-8C05-FB376D870562Q36766199-3579B849-393C-4104-9FF9-29569403F7B0Q36952130-6D428139-84D9-4AC9-968F-1A47EA11EB74Q36975782-D70FDC84-FD95-4667-BC61-9F930B29D4D1Q37124228-6905FC68-711A-406B-AC7B-CE7509332F14Q37324425-4AD3DDE6-FFC7-4A09-9E78-1C6E2F4CED28Q37349603-0E93F3DE-A3A8-422A-BBBF-8FA7639D2645Q37691121-CCA53FAA-1253-48D9-90A8-486C956BD76BQ38178937-AC89FBCD-1BBA-46C6-AB2B-B11C47469184Q38628311-8E651267-61E3-4163-BB95-6AA9C69BBAA6Q39006821-74900921-1FD7-46F5-BF8A-06BB5E0FB684Q39542957-3A6DB0D2-0213-4ACC-920D-EC0ACA151400Q40360759-5A0AF659-F207-4926-98CB-AE9134E0958EQ43186835-247A865D-0475-4266-81CA-92F00D38113BQ43198237-14C40A6C-E90A-4FCB-BCAB-7A7AE8E1EBE0Q44229940-C8CCBF91-745F-485A-A337-FF0205216A99Q44883946-243D9813-25DC-4A82-B679-F3F284F06804
P2860
Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Antimicrobial resistance and c ...... an Co-trimoxazole Study Group.
@en
Antimicrobial resistance and c ...... an Co-trimoxazole Study Group.
@nl
type
label
Antimicrobial resistance and c ...... an Co-trimoxazole Study Group.
@en
Antimicrobial resistance and c ...... an Co-trimoxazole Study Group.
@nl
prefLabel
Antimicrobial resistance and c ...... an Co-trimoxazole Study Group.
@en
Antimicrobial resistance and c ...... an Co-trimoxazole Study Group.
@nl
P2093
P921
P1433
P1476
Antimicrobial resistance and c ...... an Co-trimoxazole Study Group.
@en
P2093
P304
P356
10.1016/S0140-6736(97)10294-X
P407
P577
1998-07-01T00:00:00Z